Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
Active, not recruiting · NCT07340138 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 1 | 2026-09-09 | NCT07340138 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||